Announcements Trials

Browse Landscape

Phase

Status

Completed 25 Terminated 4 Not yet recruiting 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 28 Lymphoid 12 Myeloid 7 CNS 5 Plasma cell 4 Classical hematology 3 Sarcoma 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 77 Fulvestrant 77 Carboplatin 74 Trastuzumab 70 Capecitabine 69 Letrozole 62 Cyclophosphamide 61 Paclitaxel 60 Specimen Handling 52 pertuzumab 51 Docetaxel 49 abemaciclib 46 ribociclib 45 Anastrozole 35 130-nm albumin-bound paclitaxel 35 trastuzumab deruxtecan 34 Magnetic Resonance Spectroscopy 34 Tamoxifen 33 Blood Specimen Collection 33 sacituzumab govitecan 31 exemestane 31 Biopsy 31 Gemcitabine 30 Epirubicin 29 pyrotinib 28 palbociclib 28 Surveys and Questionnaires 27 Injections 27 Drug Therapy 27 eribulin 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Granulocyte Colony-Stimulating Factor × Breast × Clear all

NCT05753618 2026-02-09

REaCT-OGF

Ottawa Hospital Research Institute

Phase 4 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡